Wendy J. Levin
Author
Alternate names W. J. Levin, Wendy Levin, W. Levin, Wendy J. Levin
Institution Levin Group (United States)
Past institutions Levin Group (United States), Royal Free London NHS Foundation Trust, AstraZeneca (United States), AstraZeneca (United Kingdom), Fate Therapeutics (United States) +5 more
H-index: 16
I10-index: 22
Works count: 68
Citations count: 19,690
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
1987 · Dennis J. Slamon, Gary M. Clark, et al. · Science
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
1989 · Dennis J. Slamon, William Godolphin, et al. · Science
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
2020 · Thomas Powles, Michiel S. van der Heijden, et al. · The Lancet Oncology